Shares of Anpario plc (LON:ANP - Get Free Report) hit a new 52-week high during trading on Monday . The company traded as high as GBX 460 ($5.59) and last traded at GBX 454.15 ($5.52), with a volume of 67520 shares traded. The stock had previously closed at GBX 458.89 ($5.58).
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group upped their target price on shares of Anpario from GBX 380 ($4.62) to GBX 500 ($6.08) and gave the company a "buy" rating in a research note on Tuesday, January 14th.
Check Out Our Latest Stock Analysis on ANP
Anpario Stock Performance
The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of £76.80 million, a price-to-earnings ratio of 2,523.06 and a beta of 0.58. The stock has a fifty day moving average price of GBX 370.03 and a 200-day moving average price of GBX 325.13.
Insider Buying and Selling at Anpario
In other news, insider Karen Prior sold 14,000 shares of Anpario stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.62), for a total value of £53,200 ($64,704.45). Company insiders own 30.51% of the company's stock.
Anpario Company Profile
(
Get Free Report)
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Anpario, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.
While Anpario currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
